Results for: oncology

9yo helps raise cancer unit funds

New cancer centre for both public, private patients

Would you receive chemotherapy here?

Curis adds Pienta to its board

New drug to prevent breast cancer recurrence shows promise

Woman gets new face in Poland's 2nd transplant

Deal fever hits global pharma sector

Targeted therapies offer hope against aggressive cancer

Ziopharm takes bigger loss as research costs grow

Cancer costs EU $170 bln annually

Trainee doctor shares cancer experience with Tasmanian children

New treatment improves lung cancer survival rates

Ziopharm rises on preclinical cancer therapy study

FDA approves Boehringer drug for lung cancer

Pfizer to raise bid for AstraZeneca: reports

Treatment extends life for men with prostate cancer

Michael Douglas' Cancer Highlights HPV Risks

J.C. Penney, Crocs, Suntech are big movers

Roper will buy Managed Healthcare for $1 billion

Two Americans, one German take home Nobel medicine prize

Cancer teens miss out on fertility plan

Risk of dying from cancer down 20 percent: US study

Analysis - Pfizer U.S research jobs jeopardised by promises to UK for...

Walgreen, Lululemon, Skullcandy are big movers

Pfizer U.S. research jobs jeopardized by promises to UK for merger

Injection saves cancer women's ovaries, study finds

Qld hospital fights legionella outbreak

Exercise boosts cancer treatment: experts

Ziopharm's most advanced drug fails in study

Shake-up in pharma world as Novartis, GSK announce mega-deals

Study: Radiation for breast cancer can harm hearts

Pfizer earnings dip on patent expirations, taxes

Severe US flu season helped Roche's Q1 sales

AstraZeneca to buy U.S. cancer firm for up to $500 million

Surgeons face dilemma over older patients

Genome tests help tailored treatment for breast cancer

Dow, Standard and Poor 500 hit record closes

AstraZeneca to buy U.S. cancer firm for up to $500 million

Leukaemia drug could replace chemotherapy

Dendreon shares rise 4Q Provenge sales increase

Qld Health facing fundamental shake-up

European stocks rise on pharmaceutical shake-up